Skip to main content
. 2026 Sep 10;18(18):2939. doi: 10.3390/cancers18182939
ADMET absorption, distribution, metabolism, excretion, and toxicity
AI artificial intelligence
ATOM Accelerating Therapeutics for Opportunities in Medicine
CBVLS compound-based virtual ligand screening
CDISC Clinical Data Interchange Standards Consortium
CRDC Cancer Research Data Commons
CTD Common Technical Document
DL deep learning
EBI European Bioinformatics Institute
EHR electronic health records
EMA European Medicines Agency
EMBL European Molecular Biology Laboratory
EU European Union
FAIR Findable, Accessible, Interoperable, and Reusable
FDA Food and Drug Administration
FHIR Fast Healthcare Interoperability Resources
GDC Genomic Data Commons
GDPR General Data Protection Regulation
HCS high content screening
HIPAA Health Insurance Portability and Accountability Act
HTS High-Throughput Screening
ICH International Council of Harmonisation
InChI International Chemical Identifier
LLM large language model
MCTS Monte Carlo tree search
MIDD Model-Informed Drug Development
MLPCN Molecular Library Probe Production Centers Network
ML machine learning
NCI National Cancer Institute
NDA New Drug Application
NIH National Institutes of Health
OMOP Observational Medical Outcomes Partnership
PDB Protein Data Bank
PHI protected health information
QSAR quantitative structure–activity relationships
RBVLS receptor-based virtual ligand screening
RECIST Response Evaluation Criteria in Solid Tumors
RTOR Real-Time Oncology Review
RWD real-world data
RWE real-world evidence
SMILES Simplified Molecular Input Line Entry System
TCGA The Cancer Genome Atlas
US United States
USD United States dollar
VA U.S. Department of Veterans Affairs
VLS virtual ligand screening